Interview: Competitors are pulling back, Sanofi's CEO says: "It's simply logical to invest in Germany"
Almost the entire pharmaceutical industry has rejected the Chancellor. Only Sanofi boss Belén Garijo came to the government's investment summit - with a clear demand for Friedrich Merz.
Sanofi CEO Belén Garijo has expressed confidence in Germany as a business location, despite other pharmaceutical companies threatening to withdraw investments. Garijo attended the "Invest in Germany" conference in Berlin, where she met with Chancellor Friedrich Merz and emphasized that Sanofi is not just a cost factor, but a contributor to the economy.
The company is investing €2 billion in an insulin production facility in Frankfurt, its largest investment ever. Garijo also called for a more supportive environment for innovation in Europe, warning that the continent risks falling behind the US and China if it does not adapt.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
